"/> Novus Biologicals™ Peptide bloquant d’anticorps LR… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps LRRTM1

Réf. : BL-RE-083745Réf. fabricant : 18222827 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
347730
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76528. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 17 amino acid peptide near the carboxy terminus of human LRRTM1.

Points forts

Source

Synthetic

(Accession #: AAH45113) The LRRTM1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-083745
Réf. fabricant18222827
Gene ID (Entrez)347730
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76528. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneFLJ32082, leucine rich repeat transmembrane neuronal 1, leucine-rich repeat transmembrane neuronal 1 protein, leucine-rich repeat transmembrane neuronal protein 1
Symbole de gène(s)LRRTM1
Type de produitLRRTM1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne17 amino acid peptide near the carboxy terminus of human LRRTM1
Une question, une configuration particulière ?
Contactez-nous pour un devis.